Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Y Yu

Showing results (31-40 of 234) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Rapid clinical deterioration and leukemoid reaction after treatment of urothelial carcinoma of the bladder: possible effect of granulocyte colony-stimulating factorFrancisco A Perez, Corinne L Fligner, Evan Y Yu
The Urologic Clinics of North America|October 23, 2012
Advanced clinical states in prostate cancerHeather H Cheng, Daniel W Lin, Evan Y Yu
Clinical Genitourinary Cancer|April 22, 2018
Hematologic Toxicity From Radium-223 Therapy for Bone Metastases in Castration-Resistant Prostate Cancer: Risk Factors and Practical ConsiderationsHeather Jacene, Leonard Gomella, Evan Y Yu, et al.
Retinal Cases & Brief Reports|November 13, 2014
Ocular prostate cancer metastasis treated with external beam radiationRalph P Ermoian, Robert E Kalina, Evan Y Yu, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Formidable Scenarios in Urothelial and Variant Cancers of the Urinary TractJeanny B Aragon-Ching, Ananya Choudhury, Vitaly Margulis, et al.
JCO Oncology Practice|April 16, 2025
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline Clinical InsightsVeda N Giri, R Bryan Rumble, Evan Y Yu, et al.
Expert Review of Anticancer Therapy|July 18, 2024
PROTACing the androgen receptor and other emerging therapeutics in prostate cancerPeter D Zang, Allen Seylani, Evan Y Yu, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Systemic Therapy for Advanced Urothelial Carcinoma: Current Standards and Treatment ConsiderationsBrian Dietrich, Arlene O Siefker-Radtke, Sandy Srinivas, et al.
Journal for Immunotherapy of Cancer|May 23, 2023
Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate cancer: a case reportDarien E Reed-Perino, Michael Lai, Evan Y Yu, et al.
Asian Journal of Andrology|November 8, 2017
Hormone levels following surgical and medical castration: defining optimal androgen suppressionMichael T Schweizer, Michael L Hancock, Robert H Getzenberg, et al.
Pageof 24

Showing results (31-40 of 234) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Rapid clinical deterioration and leukemoid reaction after treatment of urothelial carcinoma of the bladder: possible effect of granulocyte colony-stimulating factorFrancisco A Perez, Corinne L Fligner, Evan Y Yu
The Urologic Clinics of North America|October 23, 2012
Advanced clinical states in prostate cancerHeather H Cheng, Daniel W Lin, Evan Y Yu
Clinical Genitourinary Cancer|April 22, 2018
Hematologic Toxicity From Radium-223 Therapy for Bone Metastases in Castration-Resistant Prostate Cancer: Risk Factors and Practical ConsiderationsHeather Jacene, Leonard Gomella, Evan Y Yu, et al.
Retinal Cases & Brief Reports|November 13, 2014
Ocular prostate cancer metastasis treated with external beam radiationRalph P Ermoian, Robert E Kalina, Evan Y Yu, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Formidable Scenarios in Urothelial and Variant Cancers of the Urinary TractJeanny B Aragon-Ching, Ananya Choudhury, Vitaly Margulis, et al.
JCO Oncology Practice|April 16, 2025
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline Clinical InsightsVeda N Giri, R Bryan Rumble, Evan Y Yu, et al.
Expert Review of Anticancer Therapy|July 18, 2024
PROTACing the androgen receptor and other emerging therapeutics in prostate cancerPeter D Zang, Allen Seylani, Evan Y Yu, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Systemic Therapy for Advanced Urothelial Carcinoma: Current Standards and Treatment ConsiderationsBrian Dietrich, Arlene O Siefker-Radtke, Sandy Srinivas, et al.
Journal for Immunotherapy of Cancer|May 23, 2023
Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate cancer: a case reportDarien E Reed-Perino, Michael Lai, Evan Y Yu, et al.
Asian Journal of Andrology|November 8, 2017
Hormone levels following surgical and medical castration: defining optimal androgen suppressionMichael T Schweizer, Michael L Hancock, Robert H Getzenberg, et al.
Pageof 24